https://www.dossier.today/p/big-pharma-and-big-government-link?utm_source=post-email-title&publication_id=69009&post_id=139245328&utm_campaign=email-post-title&isFreemail=true&r=1p53nh&utm_medium=email
On Tuesday, top White House officials met with pharmaceutical executives expressing mutual concern with the availability of RSV vaccines for infants and young children. RSV — which amounts to a mild cold — mortality rates are so low that most studies don’t even bother adding a mortality column. Nonetheless, it’s become the next big scare, with Pharma-Government Health snake oil salesmen fear mongering about sick infants in order to drive demand for new products.
“Senior administration officials underscored the importance of manufacturers such as Sanofi and AstraZeneca working to meet demand with a sense of urgency as we head into the winter season,” the readout said, adding that “RSV immunization, flu vaccine, and updated COVID-19 vaccines” are a must-have for the coming Winter season.
Yes, they really want you to take three “vaccines” to combat various forms of the sniffles.
And the hype is real. Search for “Tripledemic” in Google News and you’ll see that the race to scare the compliance into you is on. Check out how many stories have popped up in the past few hours alone.
Nobody gets a mere cold anymore. That’s a thing of the past. No, today, we are always labeled with an ailment that is affixed with an expensive “cure.” And what do you know, there’s plenty of new vaccines for all of that!
This time around, the likes of Pfizer and Moderna will have to join a more crowded government gravy train, with Sanofi and AstraZeneca’s seeking to join them in the Pharma marketing hype season.
Prior to the Covid-19 era, which further weaponized the pharmaceutical industry, this was simply known as Flu season.
In August, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend a second dose of Beyfortus, the brand name for the aforementioned companies’ RSV shots. It’ll be one dose for all infants younger than 8 months, and another dose between 8 to 19 months.
The thumbs up from the ACIP means Beyfortus will be available free of charge to insured families, under a provision of Obamacare that mandates insurance plans cover all ACIP-recommended vaccines.
So for people with health insurance, this means you are effectively subsidizing Big Pharma through the inevitable and continuous hikes in premiums that will result from the rampant abuse baked into Obamacare.
On Tuesday, top White House officials met with pharmaceutical executives expressing mutual concern with the availability of RSV vaccines for infants and young children. RSV — which amounts to a mild cold — mortality rates are so low that most studies don’t even bother adding a mortality column. Nonetheless, it’s become the next big scare, with Pharma-Government Health snake oil salesmen fear mongering about sick infants in order to drive demand for new products.
“Senior administration officials underscored the importance of manufacturers such as Sanofi and AstraZeneca working to meet demand with a sense of urgency as we head into the winter season,” the readout said, adding that “RSV immunization, flu vaccine, and updated COVID-19 vaccines” are a must-have for the coming Winter season.
Yes, they really want you to take three “vaccines” to combat various forms of the sniffles.
And the hype is real. Search for “Tripledemic” in Google News and you’ll see that the race to scare the compliance into you is on. Check out how many stories have popped up in the past few hours alone.
Nobody gets a mere cold anymore. That’s a thing of the past. No, today, we are always labeled with an ailment that is affixed with an expensive “cure.” And what do you know, there’s plenty of new vaccines for all of that!
This time around, the likes of Pfizer and Moderna will have to join a more crowded government gravy train, with Sanofi and AstraZeneca’s seeking to join them in the Pharma marketing hype season.
Prior to the Covid-19 era, which further weaponized the pharmaceutical industry, this was simply known as Flu season.
In August, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend a second dose of Beyfortus, the brand name for the aforementioned companies’ RSV shots. It’ll be one dose for all infants younger than 8 months, and another dose between 8 to 19 months.
The thumbs up from the ACIP means Beyfortus will be available free of charge to insured families, under a provision of Obamacare that mandates insurance plans cover all ACIP-recommended vaccines.
So for people with health insurance, this means you are effectively subsidizing Big Pharma through the inevitable and continuous hikes in premiums that will result from the rampant abuse baked into Obamacare.
https://www.dossier.today/p/big-pharma-and-big-government-link?utm_source=post-email-title&publication_id=69009&post_id=139245328&utm_campaign=email-post-title&isFreemail=true&r=1p53nh&utm_medium=email
On Tuesday, top White House officials met with pharmaceutical executives expressing mutual concern with the availability of RSV vaccines for infants and young children. RSV — which amounts to a mild cold — mortality rates are so low that most studies don’t even bother adding a mortality column. Nonetheless, it’s become the next big scare, with Pharma-Government Health snake oil salesmen fear mongering about sick infants in order to drive demand for new products.
“Senior administration officials underscored the importance of manufacturers such as Sanofi and AstraZeneca working to meet demand with a sense of urgency as we head into the winter season,” the readout said, adding that “RSV immunization, flu vaccine, and updated COVID-19 vaccines” are a must-have for the coming Winter season.
Yes, they really want you to take three “vaccines” to combat various forms of the sniffles.
And the hype is real. Search for “Tripledemic” in Google News and you’ll see that the race to scare the compliance into you is on. Check out how many stories have popped up in the past few hours alone.
Nobody gets a mere cold anymore. That’s a thing of the past. No, today, we are always labeled with an ailment that is affixed with an expensive “cure.” And what do you know, there’s plenty of new vaccines for all of that!
This time around, the likes of Pfizer and Moderna will have to join a more crowded government gravy train, with Sanofi and AstraZeneca’s seeking to join them in the Pharma marketing hype season.
Prior to the Covid-19 era, which further weaponized the pharmaceutical industry, this was simply known as Flu season.
In August, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend a second dose of Beyfortus, the brand name for the aforementioned companies’ RSV shots. It’ll be one dose for all infants younger than 8 months, and another dose between 8 to 19 months.
The thumbs up from the ACIP means Beyfortus will be available free of charge to insured families, under a provision of Obamacare that mandates insurance plans cover all ACIP-recommended vaccines.
So for people with health insurance, this means you are effectively subsidizing Big Pharma through the inevitable and continuous hikes in premiums that will result from the rampant abuse baked into Obamacare.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek